SLC5A7 and acute myeloid leukemia: In multivariable analysis, t-AML with CHT + RT was an independent poor prognostic factor for OS (HR 1.44; 95% CI: 1.09–1.91; p = 0.011) and RI (HR 1.44; 95% CI: 1.01–2.06; p = 0.042) compared to de novo AML (Table 3).